Screening compound: C39H37N3O3 (V029-4875)

Screening compound: C<sub>39</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub> (V029-4875)
Screening compound: C<sub>39</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub> (V029-4875) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C39H37N3O3 (V029-4875)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-4875

Molecular Formula

C39H37N3O3 (C39 H37 N3 O3)

Compound Name

3-(1-benzyl-1H-indol-3-yl)-3-[4-(benzyloxy)-3-methoxyphenyl]-N-[2-(pyridin-2-yl)ethyl]propanamide

IUPAC name

3-(1-benzyl-1H-indol-3-yl)-3-[4-(benzyloxy)-3-methoxyphenyl]-N-[2-(pyridin-2-yl)ethyl]propanamide

SMILES

COc(cc(C(CC(NCCc1ncccc1)=O)c1cn(Cc2ccccc2)c2c1cccc2)cc1)c1OCc1ccccc1

InChI

InChI=1S/C39H37N3O3/c1-44-38-24-31(19-20-37(38)45-28-30-14-6-3-7-15-30)34(25-39(43)41-23-21-32-16-10-11-22-40-32)35-27-42(26-29-12-4-2-5-13-29)36-18-9-8-17-33(35)36/h2-20,22,24,27,34H,21,23,25-26,28H2,1H3,(H,41,43)/t34-/m1/s1

InChI Key

JJPQYPIICMHLGO-UUWRZZSWSA-N

MDL Number (MFCD)

MFCD19779988

C39H37N3O3 (V029-4875) in Drug Discovery

Included in Screening Libraries

Indole Derivatives (10091 compounds)

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Structure:
  • Cyclic compounds
Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C39H37N3O3 (V029-4875) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C39H37N3O3 (V029-4875)?
Check Price and Availability of C39H37N3O3 (V029-4875), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C39H37N3O3 (V029-4875) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C39H37N3O3 (V029-4875)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C39H37N3O3 (V029-4875)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C39H37N3O3 (V029-4875) available by request